Aegis Ventures

Aegis Ventures (operating at aegisventures.com) is a next-generation venture studio engineered for the healthcare sector, specializing in the creation and scaling of AI-native healthtech companies. Founded in 2020 and headquartered in New York City, Aegis Ventures distinguishes itself by partnering directly with entrepreneurs and industry leaders—rather than merely funding startups—to originate, launch, and scale transformative ventures. Unlike traditional venture capital, which often injects capital into pre-existing ideas, Aegis Ventures takes a hands-on approach, embedding itself in the development process to accelerate innovation in medical devices and broader medtech ecosystems. Under the hood, the studio leverages AI-driven platforms to reshape business models, improve venture outcomes, and foster collaborations between entrepreneurs and health systems. This allows healthcare stakeholders—from clinicians to investors—to access cutting-edge solutions that address critical gaps in patient care, operational efficiency, and medical research. While specific funding details are not publicly disclosed, the studio’s focus on high-impact, AI-centric healthtech positions it as a pivotal player in the evolving intersection of technology and healthcare.